Each capsule contains Esomeprazole 40 mg + Domperidone 30 mg SR.

Esofag D Capsules combine Esomeprazole, a proton pump inhibitor, with Domperidone, a prokinetic and anti-emetic agent, to provide effective relief from Gastroesophageal Reflux Disease (GERD). The dual-action formulation suppresses gastric acid secretion while improving gastric motility, making it beneficial for patients whose symptoms are inadequately controlled with esomeprazole alone.

Esofag D Capsules are indicated for the treatment of adult patients with Gastroesophageal Reflux Disease (GERD) who do not respond adequately to esomeprazole alone.

Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specifically inhibiting the H⁺/K⁺-ATPase enzyme in gastric parietal cells. Domperidone is a dopamine receptor antagonist with prokinetic and anti-emetic properties that enhances gastric emptying and reduces symptoms such as nausea, vomiting, and reflux.

The recommended dosage is one capsule once daily before food, or as directed by the physician.

Esofag D Capsules are contraindicated in patients with known hypersensitivity to Esomeprazole, Domperidone, or any component of the formulation.